Okyo Pharma LTD (OKYO) — 20-F Filings
All 20-F filings from Okyo Pharma LTD. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
OKYO Pharma Navigates Pre-Revenue Phase, Bolsters Capital for R&D
— Jul 18, 2025 Risk: high
OKYO Pharma Ltd reported no revenue for the fiscal year ended March 31, 2025, consistent with its pre-commercialization stage as a biotechnology company. The co -
OKYO Pharma Ltd Files 20-F for FY Ending March 31, 2024
— Aug 13, 2024 Risk: medium
OKYO Pharma Ltd filed its annual 20-F report for the period ending March 31, 2024. The company, based in London, operates in the biological products sector. The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX